In this presentation, LCDR Kristin Allmaras discusses integrated MAT perspectives. […]
Keyword: mat
HCV and People Who Inject Drugs | HCV and SUD Treatment | May 4, 2021
In this series of presentations, Jessica Gregg, MD, shares information on HCV in people who inject drugs, and medications used to treat opioid use disorder. Then, Melissa McFarland, MSN, FNP-BC, shares how… […]
Read More… from HCV and People Who Inject Drugs | HCV and SUD Treatment | May 4, 2021
Substance Use Disorder | April 15, 2021
Dependence on opiates such as painkillers and heroin continue to cause overdose and trauma to families across Indian Country. There is no perfect solution, but approaches such as Harm Reduction… […]
Team Based Care & Medications for Opioid Use Disorder | April 6, 2021
In this presentation, CAPT Cynthia Gunderson discusses the impact of implicit bias and how perceptions and beliefs can impact overall community wellness, explores the role of advanced practice pharmacists in… […]
Read More… from Team Based Care & Medications for Opioid Use Disorder | April 6, 2021
Medications for OUD-Who Should Get What, When | September 10, 2020
In this presentation, Jessica Gregg, MD, PhD, SUD ECHO faculty member, provides an overview of the different medications used to treat opioid use disorder, and specifically compares methadone, buprenorphine, and… […]
Read More… from Medications for OUD-Who Should Get What, When | September 10, 2020
Siletz Community Health Clinic: Implementing a Medication-Assisted Treatment (MAT) Program | June 6, 2019
Lisa Taylor, a family nurse practitioner at Siletz Community Health Clinic, shares the story of the Siletz Community Health Clinic in creating a medication-assisted treatment program to combat the opioid… […]
Medications for OUD: Who Should Get What When? | February 7, 2019
Dr. Jessica Gregg, Associate Professor of Medicine at Oregon Health and Science University, compares buprenorphine, methadone, and extended release naltrexone in terms of efficacy, induction, retention, operational restraints, and other… […]
Read More… from Medications for OUD: Who Should Get What When? | February 7, 2019
HCV Treatment in People Receiving MAT | June 25, 2018
In these slides, Dr. Jacob Kesner, an Infectious Diseases Pharmacist at Lovelace Medical Center, discusses the relationship between people receiving MAT and HCV treatment, shares his rationale for providing HCV… […]
Read More… from HCV Treatment in People Receiving MAT | June 25, 2018











































